Global CD34+ Cell Selection Equipment Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global CD34+ Cell Selection Equipment market size was valued at US$ 84.91 million in 2025 and is forecast to a readjusted size of US$ 152 million by 2032 with a CAGR of 8.5% during review period.
CD34+ cell selection equipment refers to instruments used to perform the separation, enrichment, or selection of CD34+ hematopoietic stem and progenitor cells. The core function of this type of equipment is to obtain enriched CD34+ cell populations from complex samples such as bone marrow, cord blood, mobilized peripheral blood, leukapheresis products, or PBMCs through hardware-based processes including anti-CD34 labeling systems, magnetic separation, column-based separation, column-free separation, or bag-based magnetic separation.
From an industrial positioning perspective, CD34+ cell selection equipment is located at the intersection of life science instruments, cell therapy manufacturing equipment, and hematopoietic stem cell transplantation support equipment. Its main uses include clinical graft processing, research-grade CD34+ cell separation, cell therapy process development, sample processing before gene editing, and GMP-grade cell preparation workflows. Technological development is moving from early manual magnetic racks and open manual operations toward closed, automated, traceable, high-throughput, and GMP-compatible equipment systems. In the current market, the number of equipment suppliers is significantly smaller than the number of reagent and consumable suppliers. Global equipment supply is mainly concentrated among Miltenyi Biotec, STEMCELL Technologies, Applied Cells, and a small number of magnetic separation device suppliers. Compared with kits and magnetic beads, the equipment market is smaller in scale and has lower purchase frequency, but the value per unit is higher, customer validation cycles are longer, and barriers to entry are also higher. The upstream segment of this type of equipment mainly includes magnet components, precision pumps and valves, fluidic control modules, sensors, touchscreens and embedded control systems, disposable tubing adaptation structures, electromechanical integrated components, quality management systems, and GMP validation capabilities. The reliability of upstream equipment directly affects cell recovery rate, cell viability, batch-to-batch consistency, sterility assurance, and process traceability. Downstream customers mainly include hematopoietic stem cell transplantation centers, hematology and oncology departments, cell therapy companies, gene-editing therapy companies, cell process development laboratories, CROs, CDMOs, and large research institutions. Downstream demand is not equivalent to the total number of hematopoietic stem cell transplantations, because only some transplantation and cell therapy workflows require CD34+ cell selection equipment. Nevertheless, HCT and cell therapy activities still form an important demand base. The EBMT report shows that HCT activity in Europe and surrounding regions reached 47,731 cases in 2023, with allogeneic HCT increasing by 7.8% year on year and CAR-T therapy increasing by 52.5%, indicating that transplantation and advanced cell therapy activities are still expanding. In terms of policy, the U.S. FDA has approved the CliniMACS CD34 Reagent System for specific AML patient settings, and gene therapy products based on enriched CD34+ cell populations, such as CASGEVY, have also been approved. These developments are increasing the importance of clinical-grade, closed, and verifiable cell processing equipment. Future trends in pricing, production volume, and market size will differ from those of reagents and consumables. Equipment prices are unlikely to decline rapidly like ordinary consumables, because their value mainly comes from hardware reliability, software control, closed processing workflows, GMP compatibility, after-sales service, validation documentation, and customer process lock-in. However, research-grade automated separators and semi-automated magnetic separation devices may experience gradual unit price declines due to intensified competition and domestic substitution. In terms of production volume, annual shipments of clinical-grade closed equipment will continue to show the characteristics of small batches and high unit prices, while shipments of research-grade automation equipment and process development equipment are expected to grow faster, mainly driven by cell therapy process development, CD34+ gene-editing research, and laboratory automation demand. This market is not a large-scale consumables market, but a small-scale, high-barrier specialized equipment market that is gradually expanding alongside the automation of cell therapy manufacturing.
This report is a detailed and comprehensive analysis for global CD34+ Cell Selection Equipment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Technology Route and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global CD34+ Cell Selection Equipment market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global CD34+ Cell Selection Equipment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global CD34+ Cell Selection Equipment market size and forecasts, by Technology Route and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global CD34+ Cell Selection Equipment market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
CD34+ Cell Selection Equipment market is split by Technology Route and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Technology Route, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Technology Route
Chapter 1, to describe CD34+ Cell Selection Equipment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of CD34+ Cell Selection Equipment, with price, sales quantity, revenue, and global market share of CD34+ Cell Selection Equipment from 2021 to 2026.
Chapter 3, the CD34+ Cell Selection Equipment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the CD34+ Cell Selection Equipment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Technology Route and by Application, with sales market share and growth rate by Technology Route, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and CD34+ Cell Selection Equipment market forecast, by regions, by Technology Route, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of CD34+ Cell Selection Equipment.
Chapter 14 and 15, to describe CD34+ Cell Selection Equipment sales channel, distributors, customers, research findings and conclusion.
CD34+ cell selection equipment refers to instruments used to perform the separation, enrichment, or selection of CD34+ hematopoietic stem and progenitor cells. The core function of this type of equipment is to obtain enriched CD34+ cell populations from complex samples such as bone marrow, cord blood, mobilized peripheral blood, leukapheresis products, or PBMCs through hardware-based processes including anti-CD34 labeling systems, magnetic separation, column-based separation, column-free separation, or bag-based magnetic separation.
From an industrial positioning perspective, CD34+ cell selection equipment is located at the intersection of life science instruments, cell therapy manufacturing equipment, and hematopoietic stem cell transplantation support equipment. Its main uses include clinical graft processing, research-grade CD34+ cell separation, cell therapy process development, sample processing before gene editing, and GMP-grade cell preparation workflows. Technological development is moving from early manual magnetic racks and open manual operations toward closed, automated, traceable, high-throughput, and GMP-compatible equipment systems. In the current market, the number of equipment suppliers is significantly smaller than the number of reagent and consumable suppliers. Global equipment supply is mainly concentrated among Miltenyi Biotec, STEMCELL Technologies, Applied Cells, and a small number of magnetic separation device suppliers. Compared with kits and magnetic beads, the equipment market is smaller in scale and has lower purchase frequency, but the value per unit is higher, customer validation cycles are longer, and barriers to entry are also higher. The upstream segment of this type of equipment mainly includes magnet components, precision pumps and valves, fluidic control modules, sensors, touchscreens and embedded control systems, disposable tubing adaptation structures, electromechanical integrated components, quality management systems, and GMP validation capabilities. The reliability of upstream equipment directly affects cell recovery rate, cell viability, batch-to-batch consistency, sterility assurance, and process traceability. Downstream customers mainly include hematopoietic stem cell transplantation centers, hematology and oncology departments, cell therapy companies, gene-editing therapy companies, cell process development laboratories, CROs, CDMOs, and large research institutions. Downstream demand is not equivalent to the total number of hematopoietic stem cell transplantations, because only some transplantation and cell therapy workflows require CD34+ cell selection equipment. Nevertheless, HCT and cell therapy activities still form an important demand base. The EBMT report shows that HCT activity in Europe and surrounding regions reached 47,731 cases in 2023, with allogeneic HCT increasing by 7.8% year on year and CAR-T therapy increasing by 52.5%, indicating that transplantation and advanced cell therapy activities are still expanding. In terms of policy, the U.S. FDA has approved the CliniMACS CD34 Reagent System for specific AML patient settings, and gene therapy products based on enriched CD34+ cell populations, such as CASGEVY, have also been approved. These developments are increasing the importance of clinical-grade, closed, and verifiable cell processing equipment. Future trends in pricing, production volume, and market size will differ from those of reagents and consumables. Equipment prices are unlikely to decline rapidly like ordinary consumables, because their value mainly comes from hardware reliability, software control, closed processing workflows, GMP compatibility, after-sales service, validation documentation, and customer process lock-in. However, research-grade automated separators and semi-automated magnetic separation devices may experience gradual unit price declines due to intensified competition and domestic substitution. In terms of production volume, annual shipments of clinical-grade closed equipment will continue to show the characteristics of small batches and high unit prices, while shipments of research-grade automation equipment and process development equipment are expected to grow faster, mainly driven by cell therapy process development, CD34+ gene-editing research, and laboratory automation demand. This market is not a large-scale consumables market, but a small-scale, high-barrier specialized equipment market that is gradually expanding alongside the automation of cell therapy manufacturing.
This report is a detailed and comprehensive analysis for global CD34+ Cell Selection Equipment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Technology Route and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global CD34+ Cell Selection Equipment market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global CD34+ Cell Selection Equipment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global CD34+ Cell Selection Equipment market size and forecasts, by Technology Route and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global CD34+ Cell Selection Equipment market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for CD34+ Cell Selection Equipment
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
CD34+ Cell Selection Equipment market is split by Technology Route and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Technology Route, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Technology Route
- Column-Based Immunomagnetic Selection
- Column-Free Immunomagnetic Selection
- Buoyancy-Activated Microbubble Sorting
- Closed Clinical System
- Laboratory Selection Kit
- Platform-Based Selection Instrument
- Direct Positive Selection
- Direct Negative Enrichment
- Pre-Enrichment Followed By Positive Selection
- Clinical Transplant Cell Preparation
- Research-Use Cell Isolation
- Process Development And Translational Research
- Miltenyi Biotec GmbH
- STEMCELL Technologies Inc.
- Thermo Fisher Scientific Inc.
- Applied Cells, Inc.
- Akadeum Life Sciences, Inc.
- Bio-Techne Corporation
- Revvity, Inc.
- GenScript Biotech Corporation
- Beaver Biomedical Engineering Co., Ltd.
- Suzhou Xinxie Biotechnology Co., Ltd.
- APExBIO Technology LLC
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe CD34+ Cell Selection Equipment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of CD34+ Cell Selection Equipment, with price, sales quantity, revenue, and global market share of CD34+ Cell Selection Equipment from 2021 to 2026.
Chapter 3, the CD34+ Cell Selection Equipment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the CD34+ Cell Selection Equipment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Technology Route and by Application, with sales market share and growth rate by Technology Route, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and CD34+ Cell Selection Equipment market forecast, by regions, by Technology Route, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of CD34+ Cell Selection Equipment.
Chapter 14 and 15, to describe CD34+ Cell Selection Equipment sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Technology Route
1.3.1 Overview: Global CD34+ Cell Selection Equipment Consumption Value by Technology Route: 2021 Versus 2025 Versus 2032
1.3.2 Column-Based Immunomagnetic Selection
1.3.3 Column-Free Immunomagnetic Selection
1.3.4 Buoyancy-Activated Microbubble Sorting
1.4 Market Analysis by Product Delivery Form
1.4.1 Overview: Global CD34+ Cell Selection Equipment Consumption Value by Product Delivery Form: 2021 Versus 2025 Versus 2032
1.4.2 Closed Clinical System
1.4.3 Laboratory Selection Kit
1.4.4 Platform-Based Selection Instrument
1.5 Market Analysis by CD34+ Cell Acquisition Workflow
1.5.1 Overview: Global CD34+ Cell Selection Equipment Consumption Value by CD34+ Cell Acquisition Workflow: 2021 Versus 2025 Versus 2032
1.5.2 Direct Positive Selection
1.5.3 Direct Negative Enrichment
1.5.4 Pre-Enrichment Followed By Positive Selection
1.6 Market Analysis by Application
1.6.1 Overview: Global CD34+ Cell Selection Equipment Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Clinical Transplant Cell Preparation
1.6.3 Research-Use Cell Isolation
1.6.4 Process Development And Translational Research
1.7 Global CD34+ Cell Selection Equipment Market Size & Forecast
1.7.1 Global CD34+ Cell Selection Equipment Consumption Value (2021 & 2025 & 2032)
1.7.2 Global CD34+ Cell Selection Equipment Sales Quantity (2021-2032)
1.7.3 Global CD34+ Cell Selection Equipment Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Miltenyi Biotec GmbH
2.1.1 Miltenyi Biotec GmbH Details
2.1.2 Miltenyi Biotec GmbH Major Business
2.1.3 Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Product and Services
2.1.4 Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Miltenyi Biotec GmbH Recent Developments/Updates
2.2 STEMCELL Technologies Inc.
2.2.1 STEMCELL Technologies Inc. Details
2.2.2 STEMCELL Technologies Inc. Major Business
2.2.3 STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Product and Services
2.2.4 STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 STEMCELL Technologies Inc. Recent Developments/Updates
2.3 Thermo Fisher Scientific Inc.
2.3.1 Thermo Fisher Scientific Inc. Details
2.3.2 Thermo Fisher Scientific Inc. Major Business
2.3.3 Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Product and Services
2.3.4 Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
2.4 Applied Cells, Inc.
2.4.1 Applied Cells, Inc. Details
2.4.2 Applied Cells, Inc. Major Business
2.4.3 Applied Cells, Inc. CD34+ Cell Selection Equipment Product and Services
2.4.4 Applied Cells, Inc. CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Applied Cells, Inc. Recent Developments/Updates
2.5 Akadeum Life Sciences, Inc.
2.5.1 Akadeum Life Sciences, Inc. Details
2.5.2 Akadeum Life Sciences, Inc. Major Business
2.5.3 Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Product and Services
2.5.4 Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Akadeum Life Sciences, Inc. Recent Developments/Updates
2.6 Bio-Techne Corporation
2.6.1 Bio-Techne Corporation Details
2.6.2 Bio-Techne Corporation Major Business
2.6.3 Bio-Techne Corporation CD34+ Cell Selection Equipment Product and Services
2.6.4 Bio-Techne Corporation CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Bio-Techne Corporation Recent Developments/Updates
2.7 Revvity, Inc.
2.7.1 Revvity, Inc. Details
2.7.2 Revvity, Inc. Major Business
2.7.3 Revvity, Inc. CD34+ Cell Selection Equipment Product and Services
2.7.4 Revvity, Inc. CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Revvity, Inc. Recent Developments/Updates
2.8 GenScript Biotech Corporation
2.8.1 GenScript Biotech Corporation Details
2.8.2 GenScript Biotech Corporation Major Business
2.8.3 GenScript Biotech Corporation CD34+ Cell Selection Equipment Product and Services
2.8.4 GenScript Biotech Corporation CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 GenScript Biotech Corporation Recent Developments/Updates
2.9 Beaver Biomedical Engineering Co., Ltd.
2.9.1 Beaver Biomedical Engineering Co., Ltd. Details
2.9.2 Beaver Biomedical Engineering Co., Ltd. Major Business
2.9.3 Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Product and Services
2.9.4 Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Beaver Biomedical Engineering Co., Ltd. Recent Developments/Updates
2.10 Suzhou Xinxie Biotechnology Co., Ltd.
2.10.1 Suzhou Xinxie Biotechnology Co., Ltd. Details
2.10.2 Suzhou Xinxie Biotechnology Co., Ltd. Major Business
2.10.3 Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Product and Services
2.10.4 Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Suzhou Xinxie Biotechnology Co., Ltd. Recent Developments/Updates
2.11 APExBIO Technology LLC
2.11.1 APExBIO Technology LLC Details
2.11.2 APExBIO Technology LLC Major Business
2.11.3 APExBIO Technology LLC CD34+ Cell Selection Equipment Product and Services
2.11.4 APExBIO Technology LLC CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 APExBIO Technology LLC Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CD34+ CELL SELECTION EQUIPMENT BY MANUFACTURER
3.1 Global CD34+ Cell Selection Equipment Sales Quantity by Manufacturer (2021-2026)
3.2 Global CD34+ Cell Selection Equipment Revenue by Manufacturer (2021-2026)
3.3 Global CD34+ Cell Selection Equipment Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of CD34+ Cell Selection Equipment by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 CD34+ Cell Selection Equipment Manufacturer Market Share in 2025
3.4.3 Top 6 CD34+ Cell Selection Equipment Manufacturer Market Share in 2025
3.5 CD34+ Cell Selection Equipment Market: Overall Company Footprint Analysis
3.5.1 CD34+ Cell Selection Equipment Market: Region Footprint
3.5.2 CD34+ Cell Selection Equipment Market: Company Product Type Footprint
3.5.3 CD34+ Cell Selection Equipment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global CD34+ Cell Selection Equipment Market Size by Region
4.1.1 Global CD34+ Cell Selection Equipment Sales Quantity by Region (2021-2032)
4.1.2 Global CD34+ Cell Selection Equipment Consumption Value by Region (2021-2032)
4.1.3 Global CD34+ Cell Selection Equipment Average Price by Region (2021-2032)
4.2 North America CD34+ Cell Selection Equipment Consumption Value (2021-2032)
4.3 Europe CD34+ Cell Selection Equipment Consumption Value (2021-2032)
4.4 Asia-Pacific CD34+ Cell Selection Equipment Consumption Value (2021-2032)
4.5 South America CD34+ Cell Selection Equipment Consumption Value (2021-2032)
4.6 Middle East & Africa CD34+ Cell Selection Equipment Consumption Value (2021-2032)
5 MARKET SEGMENT BY TECHNOLOGY ROUTE
5.1 Global CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2032)
5.2 Global CD34+ Cell Selection Equipment Consumption Value by Technology Route (2021-2032)
5.3 Global CD34+ Cell Selection Equipment Average Price by Technology Route (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2032)
6.2 Global CD34+ Cell Selection Equipment Consumption Value by Application (2021-2032)
6.3 Global CD34+ Cell Selection Equipment Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2032)
7.2 North America CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2032)
7.3 North America CD34+ Cell Selection Equipment Market Size by Country
7.3.1 North America CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2032)
7.3.2 North America CD34+ Cell Selection Equipment Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2032)
8.2 Europe CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2032)
8.3 Europe CD34+ Cell Selection Equipment Market Size by Country
8.3.1 Europe CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2032)
8.3.2 Europe CD34+ Cell Selection Equipment Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2032)
9.2 Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific CD34+ Cell Selection Equipment Market Size by Region
9.3.1 Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific CD34+ Cell Selection Equipment Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2032)
10.2 South America CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2032)
10.3 South America CD34+ Cell Selection Equipment Market Size by Country
10.3.1 South America CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2032)
10.3.2 South America CD34+ Cell Selection Equipment Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2032)
11.2 Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa CD34+ Cell Selection Equipment Market Size by Country
11.3.1 Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa CD34+ Cell Selection Equipment Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 CD34+ Cell Selection Equipment Market Drivers
12.2 CD34+ Cell Selection Equipment Market Restraints
12.3 CD34+ Cell Selection Equipment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of CD34+ Cell Selection Equipment and Key Manufacturers
13.2 Manufacturing Costs Percentage of CD34+ Cell Selection Equipment
13.3 CD34+ Cell Selection Equipment Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 CD34+ Cell Selection Equipment Typical Distributors
14.3 CD34+ Cell Selection Equipment Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Technology Route
1.3.1 Overview: Global CD34+ Cell Selection Equipment Consumption Value by Technology Route: 2021 Versus 2025 Versus 2032
1.3.2 Column-Based Immunomagnetic Selection
1.3.3 Column-Free Immunomagnetic Selection
1.3.4 Buoyancy-Activated Microbubble Sorting
1.4 Market Analysis by Product Delivery Form
1.4.1 Overview: Global CD34+ Cell Selection Equipment Consumption Value by Product Delivery Form: 2021 Versus 2025 Versus 2032
1.4.2 Closed Clinical System
1.4.3 Laboratory Selection Kit
1.4.4 Platform-Based Selection Instrument
1.5 Market Analysis by CD34+ Cell Acquisition Workflow
1.5.1 Overview: Global CD34+ Cell Selection Equipment Consumption Value by CD34+ Cell Acquisition Workflow: 2021 Versus 2025 Versus 2032
1.5.2 Direct Positive Selection
1.5.3 Direct Negative Enrichment
1.5.4 Pre-Enrichment Followed By Positive Selection
1.6 Market Analysis by Application
1.6.1 Overview: Global CD34+ Cell Selection Equipment Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Clinical Transplant Cell Preparation
1.6.3 Research-Use Cell Isolation
1.6.4 Process Development And Translational Research
1.7 Global CD34+ Cell Selection Equipment Market Size & Forecast
1.7.1 Global CD34+ Cell Selection Equipment Consumption Value (2021 & 2025 & 2032)
1.7.2 Global CD34+ Cell Selection Equipment Sales Quantity (2021-2032)
1.7.3 Global CD34+ Cell Selection Equipment Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Miltenyi Biotec GmbH
2.1.1 Miltenyi Biotec GmbH Details
2.1.2 Miltenyi Biotec GmbH Major Business
2.1.3 Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Product and Services
2.1.4 Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Miltenyi Biotec GmbH Recent Developments/Updates
2.2 STEMCELL Technologies Inc.
2.2.1 STEMCELL Technologies Inc. Details
2.2.2 STEMCELL Technologies Inc. Major Business
2.2.3 STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Product and Services
2.2.4 STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 STEMCELL Technologies Inc. Recent Developments/Updates
2.3 Thermo Fisher Scientific Inc.
2.3.1 Thermo Fisher Scientific Inc. Details
2.3.2 Thermo Fisher Scientific Inc. Major Business
2.3.3 Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Product and Services
2.3.4 Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
2.4 Applied Cells, Inc.
2.4.1 Applied Cells, Inc. Details
2.4.2 Applied Cells, Inc. Major Business
2.4.3 Applied Cells, Inc. CD34+ Cell Selection Equipment Product and Services
2.4.4 Applied Cells, Inc. CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Applied Cells, Inc. Recent Developments/Updates
2.5 Akadeum Life Sciences, Inc.
2.5.1 Akadeum Life Sciences, Inc. Details
2.5.2 Akadeum Life Sciences, Inc. Major Business
2.5.3 Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Product and Services
2.5.4 Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Akadeum Life Sciences, Inc. Recent Developments/Updates
2.6 Bio-Techne Corporation
2.6.1 Bio-Techne Corporation Details
2.6.2 Bio-Techne Corporation Major Business
2.6.3 Bio-Techne Corporation CD34+ Cell Selection Equipment Product and Services
2.6.4 Bio-Techne Corporation CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Bio-Techne Corporation Recent Developments/Updates
2.7 Revvity, Inc.
2.7.1 Revvity, Inc. Details
2.7.2 Revvity, Inc. Major Business
2.7.3 Revvity, Inc. CD34+ Cell Selection Equipment Product and Services
2.7.4 Revvity, Inc. CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Revvity, Inc. Recent Developments/Updates
2.8 GenScript Biotech Corporation
2.8.1 GenScript Biotech Corporation Details
2.8.2 GenScript Biotech Corporation Major Business
2.8.3 GenScript Biotech Corporation CD34+ Cell Selection Equipment Product and Services
2.8.4 GenScript Biotech Corporation CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 GenScript Biotech Corporation Recent Developments/Updates
2.9 Beaver Biomedical Engineering Co., Ltd.
2.9.1 Beaver Biomedical Engineering Co., Ltd. Details
2.9.2 Beaver Biomedical Engineering Co., Ltd. Major Business
2.9.3 Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Product and Services
2.9.4 Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Beaver Biomedical Engineering Co., Ltd. Recent Developments/Updates
2.10 Suzhou Xinxie Biotechnology Co., Ltd.
2.10.1 Suzhou Xinxie Biotechnology Co., Ltd. Details
2.10.2 Suzhou Xinxie Biotechnology Co., Ltd. Major Business
2.10.3 Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Product and Services
2.10.4 Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Suzhou Xinxie Biotechnology Co., Ltd. Recent Developments/Updates
2.11 APExBIO Technology LLC
2.11.1 APExBIO Technology LLC Details
2.11.2 APExBIO Technology LLC Major Business
2.11.3 APExBIO Technology LLC CD34+ Cell Selection Equipment Product and Services
2.11.4 APExBIO Technology LLC CD34+ Cell Selection Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 APExBIO Technology LLC Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CD34+ CELL SELECTION EQUIPMENT BY MANUFACTURER
3.1 Global CD34+ Cell Selection Equipment Sales Quantity by Manufacturer (2021-2026)
3.2 Global CD34+ Cell Selection Equipment Revenue by Manufacturer (2021-2026)
3.3 Global CD34+ Cell Selection Equipment Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of CD34+ Cell Selection Equipment by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 CD34+ Cell Selection Equipment Manufacturer Market Share in 2025
3.4.3 Top 6 CD34+ Cell Selection Equipment Manufacturer Market Share in 2025
3.5 CD34+ Cell Selection Equipment Market: Overall Company Footprint Analysis
3.5.1 CD34+ Cell Selection Equipment Market: Region Footprint
3.5.2 CD34+ Cell Selection Equipment Market: Company Product Type Footprint
3.5.3 CD34+ Cell Selection Equipment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global CD34+ Cell Selection Equipment Market Size by Region
4.1.1 Global CD34+ Cell Selection Equipment Sales Quantity by Region (2021-2032)
4.1.2 Global CD34+ Cell Selection Equipment Consumption Value by Region (2021-2032)
4.1.3 Global CD34+ Cell Selection Equipment Average Price by Region (2021-2032)
4.2 North America CD34+ Cell Selection Equipment Consumption Value (2021-2032)
4.3 Europe CD34+ Cell Selection Equipment Consumption Value (2021-2032)
4.4 Asia-Pacific CD34+ Cell Selection Equipment Consumption Value (2021-2032)
4.5 South America CD34+ Cell Selection Equipment Consumption Value (2021-2032)
4.6 Middle East & Africa CD34+ Cell Selection Equipment Consumption Value (2021-2032)
5 MARKET SEGMENT BY TECHNOLOGY ROUTE
5.1 Global CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2032)
5.2 Global CD34+ Cell Selection Equipment Consumption Value by Technology Route (2021-2032)
5.3 Global CD34+ Cell Selection Equipment Average Price by Technology Route (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2032)
6.2 Global CD34+ Cell Selection Equipment Consumption Value by Application (2021-2032)
6.3 Global CD34+ Cell Selection Equipment Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2032)
7.2 North America CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2032)
7.3 North America CD34+ Cell Selection Equipment Market Size by Country
7.3.1 North America CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2032)
7.3.2 North America CD34+ Cell Selection Equipment Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2032)
8.2 Europe CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2032)
8.3 Europe CD34+ Cell Selection Equipment Market Size by Country
8.3.1 Europe CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2032)
8.3.2 Europe CD34+ Cell Selection Equipment Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2032)
9.2 Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific CD34+ Cell Selection Equipment Market Size by Region
9.3.1 Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific CD34+ Cell Selection Equipment Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2032)
10.2 South America CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2032)
10.3 South America CD34+ Cell Selection Equipment Market Size by Country
10.3.1 South America CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2032)
10.3.2 South America CD34+ Cell Selection Equipment Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2032)
11.2 Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa CD34+ Cell Selection Equipment Market Size by Country
11.3.1 Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa CD34+ Cell Selection Equipment Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 CD34+ Cell Selection Equipment Market Drivers
12.2 CD34+ Cell Selection Equipment Market Restraints
12.3 CD34+ Cell Selection Equipment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of CD34+ Cell Selection Equipment and Key Manufacturers
13.2 Manufacturing Costs Percentage of CD34+ Cell Selection Equipment
13.3 CD34+ Cell Selection Equipment Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 CD34+ Cell Selection Equipment Typical Distributors
14.3 CD34+ Cell Selection Equipment Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global CD34+ Cell Selection Equipment Consumption Value by Technology Route, (USD Million), 2021 & 2025 & 2032
Table 2. Global CD34+ Cell Selection Equipment Consumption Value by Product Delivery Form, (USD Million), 2021 & 2025 & 2032
Table 3. Global CD34+ Cell Selection Equipment Consumption Value by CD34+ Cell Acquisition Workflow, (USD Million), 2021 & 2025 & 2032
Table 4. Global CD34+ Cell Selection Equipment Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Miltenyi Biotec GmbH Basic Information, Manufacturing Base and Competitors
Table 6. Miltenyi Biotec GmbH Major Business
Table 7. Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Product and Services
Table 8. Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Miltenyi Biotec GmbH Recent Developments/Updates
Table 10. STEMCELL Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table 11. STEMCELL Technologies Inc. Major Business
Table 12. STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Product and Services
Table 13. STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. STEMCELL Technologies Inc. Recent Developments/Updates
Table 15. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Thermo Fisher Scientific Inc. Major Business
Table 17. Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Product and Services
Table 18. Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 20. Applied Cells, Inc. Basic Information, Manufacturing Base and Competitors
Table 21. Applied Cells, Inc. Major Business
Table 22. Applied Cells, Inc. CD34+ Cell Selection Equipment Product and Services
Table 23. Applied Cells, Inc. CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Applied Cells, Inc. Recent Developments/Updates
Table 25. Akadeum Life Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 26. Akadeum Life Sciences, Inc. Major Business
Table 27. Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Product and Services
Table 28. Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Akadeum Life Sciences, Inc. Recent Developments/Updates
Table 30. Bio-Techne Corporation Basic Information, Manufacturing Base and Competitors
Table 31. Bio-Techne Corporation Major Business
Table 32. Bio-Techne Corporation CD34+ Cell Selection Equipment Product and Services
Table 33. Bio-Techne Corporation CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Bio-Techne Corporation Recent Developments/Updates
Table 35. Revvity, Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Revvity, Inc. Major Business
Table 37. Revvity, Inc. CD34+ Cell Selection Equipment Product and Services
Table 38. Revvity, Inc. CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Revvity, Inc. Recent Developments/Updates
Table 40. GenScript Biotech Corporation Basic Information, Manufacturing Base and Competitors
Table 41. GenScript Biotech Corporation Major Business
Table 42. GenScript Biotech Corporation CD34+ Cell Selection Equipment Product and Services
Table 43. GenScript Biotech Corporation CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. GenScript Biotech Corporation Recent Developments/Updates
Table 45. Beaver Biomedical Engineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 46. Beaver Biomedical Engineering Co., Ltd. Major Business
Table 47. Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Product and Services
Table 48. Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Beaver Biomedical Engineering Co., Ltd. Recent Developments/Updates
Table 50. Suzhou Xinxie Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 51. Suzhou Xinxie Biotechnology Co., Ltd. Major Business
Table 52. Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Product and Services
Table 53. Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Suzhou Xinxie Biotechnology Co., Ltd. Recent Developments/Updates
Table 55. APExBIO Technology LLC Basic Information, Manufacturing Base and Competitors
Table 56. APExBIO Technology LLC Major Business
Table 57. APExBIO Technology LLC CD34+ Cell Selection Equipment Product and Services
Table 58. APExBIO Technology LLC CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. APExBIO Technology LLC Recent Developments/Updates
Table 60. Global CD34+ Cell Selection Equipment Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 61. Global CD34+ Cell Selection Equipment Revenue by Manufacturer (2021-2026) & (USD Million)
Table 62. Global CD34+ Cell Selection Equipment Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 63. Market Position of Manufacturers in CD34+ Cell Selection Equipment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 64. Head Office and CD34+ Cell Selection Equipment Production Site of Key Manufacturer
Table 65. CD34+ Cell Selection Equipment Market: Company Product Type Footprint
Table 66. CD34+ Cell Selection Equipment Market: Company Product Application Footprint
Table 67. CD34+ Cell Selection Equipment New Market Entrants and Barriers to Market Entry
Table 68. CD34+ Cell Selection Equipment Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global CD34+ Cell Selection Equipment Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 70. Global CD34+ Cell Selection Equipment Sales Quantity by Region (2021-2026) & (Units)
Table 71. Global CD34+ Cell Selection Equipment Sales Quantity by Region (2027-2032) & (Units)
Table 72. Global CD34+ Cell Selection Equipment Consumption Value by Region (2021-2026) & (USD Million)
Table 73. Global CD34+ Cell Selection Equipment Consumption Value by Region (2027-2032) & (USD Million)
Table 74. Global CD34+ Cell Selection Equipment Average Price by Region (2021-2026) & (US$/Unit)
Table 75. Global CD34+ Cell Selection Equipment Average Price by Region (2027-2032) & (US$/Unit)
Table 76. Global CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2026) & (Units)
Table 77. Global CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2027-2032) & (Units)
Table 78. Global CD34+ Cell Selection Equipment Consumption Value by Technology Route (2021-2026) & (USD Million)
Table 79. Global CD34+ Cell Selection Equipment Consumption Value by Technology Route (2027-2032) & (USD Million)
Table 80. Global CD34+ Cell Selection Equipment Average Price by Technology Route (2021-2026) & (US$/Unit)
Table 81. Global CD34+ Cell Selection Equipment Average Price by Technology Route (2027-2032) & (US$/Unit)
Table 82. Global CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2026) & (Units)
Table 83. Global CD34+ Cell Selection Equipment Sales Quantity by Application (2027-2032) & (Units)
Table 84. Global CD34+ Cell Selection Equipment Consumption Value by Application (2021-2026) & (USD Million)
Table 85. Global CD34+ Cell Selection Equipment Consumption Value by Application (2027-2032) & (USD Million)
Table 86. Global CD34+ Cell Selection Equipment Average Price by Application (2021-2026) & (US$/Unit)
Table 87. Global CD34+ Cell Selection Equipment Average Price by Application (2027-2032) & (US$/Unit)
Table 88. North America CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2026) & (Units)
Table 89. North America CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2027-2032) & (Units)
Table 90. North America CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2026) & (Units)
Table 91. North America CD34+ Cell Selection Equipment Sales Quantity by Application (2027-2032) & (Units)
Table 92. North America CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2026) & (Units)
Table 93. North America CD34+ Cell Selection Equipment Sales Quantity by Country (2027-2032) & (Units)
Table 94. North America CD34+ Cell Selection Equipment Consumption Value by Country (2021-2026) & (USD Million)
Table 95. North America CD34+ Cell Selection Equipment Consumption Value by Country (2027-2032) & (USD Million)
Table 96. Europe CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2026) & (Units)
Table 97. Europe CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2027-2032) & (Units)
Table 98. Europe CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2026) & (Units)
Table 99. Europe CD34+ Cell Selection Equipment Sales Quantity by Application (2027-2032) & (Units)
Table 100. Europe CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2026) & (Units)
Table 101. Europe CD34+ Cell Selection Equipment Sales Quantity by Country (2027-2032) & (Units)
Table 102. Europe CD34+ Cell Selection Equipment Consumption Value by Country (2021-2026) & (USD Million)
Table 103. Europe CD34+ Cell Selection Equipment Consumption Value by Country (2027-2032) & (USD Million)
Table 104. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2026) & (Units)
Table 105. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2027-2032) & (Units)
Table 106. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2026) & (Units)
Table 107. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Application (2027-2032) & (Units)
Table 108. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Region (2021-2026) & (Units)
Table 109. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Region (2027-2032) & (Units)
Table 110. Asia-Pacific CD34+ Cell Selection Equipment Consumption Value by Region (2021-2026) & (USD Million)
Table 111. Asia-Pacific CD34+ Cell Selection Equipment Consumption Value by Region (2027-2032) & (USD Million)
Table 112. South America CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2026) & (Units)
Table 113. South America CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2027-2032) & (Units)
Table 114. South America CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2026) & (Units)
Table 115. South America CD34+ Cell Selection Equipment Sales Quantity by Application (2027-2032) & (Units)
Table 116. South America CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2026) & (Units)
Table 117. South America CD34+ Cell Selection Equipment Sales Quantity by Country (2027-2032) & (Units)
Table 118. South America CD34+ Cell Selection Equipment Consumption Value by Country (2021-2026) & (USD Million)
Table 119. South America CD34+ Cell Selection Equipment Consumption Value by Country (2027-2032) & (USD Million)
Table 120. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2026) & (Units)
Table 121. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2027-2032) & (Units)
Table 122. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2026) & (Units)
Table 123. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Application (2027-2032) & (Units)
Table 124. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2026) & (Units)
Table 125. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Country (2027-2032) & (Units)
Table 126. Middle East & Africa CD34+ Cell Selection Equipment Consumption Value by Country (2021-2026) & (USD Million)
Table 127. Middle East & Africa CD34+ Cell Selection Equipment Consumption Value by Country (2027-2032) & (USD Million)
Table 128. CD34+ Cell Selection Equipment Raw Material
Table 129. Key Manufacturers of CD34+ Cell Selection Equipment Raw Materials
Table 130. CD34+ Cell Selection Equipment Typical Distributors
Table 131. CD34+ Cell Selection Equipment Typical Customers
Table 1. Global CD34+ Cell Selection Equipment Consumption Value by Technology Route, (USD Million), 2021 & 2025 & 2032
Table 2. Global CD34+ Cell Selection Equipment Consumption Value by Product Delivery Form, (USD Million), 2021 & 2025 & 2032
Table 3. Global CD34+ Cell Selection Equipment Consumption Value by CD34+ Cell Acquisition Workflow, (USD Million), 2021 & 2025 & 2032
Table 4. Global CD34+ Cell Selection Equipment Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Miltenyi Biotec GmbH Basic Information, Manufacturing Base and Competitors
Table 6. Miltenyi Biotec GmbH Major Business
Table 7. Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Product and Services
Table 8. Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Miltenyi Biotec GmbH Recent Developments/Updates
Table 10. STEMCELL Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table 11. STEMCELL Technologies Inc. Major Business
Table 12. STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Product and Services
Table 13. STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. STEMCELL Technologies Inc. Recent Developments/Updates
Table 15. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Thermo Fisher Scientific Inc. Major Business
Table 17. Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Product and Services
Table 18. Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 20. Applied Cells, Inc. Basic Information, Manufacturing Base and Competitors
Table 21. Applied Cells, Inc. Major Business
Table 22. Applied Cells, Inc. CD34+ Cell Selection Equipment Product and Services
Table 23. Applied Cells, Inc. CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Applied Cells, Inc. Recent Developments/Updates
Table 25. Akadeum Life Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 26. Akadeum Life Sciences, Inc. Major Business
Table 27. Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Product and Services
Table 28. Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Akadeum Life Sciences, Inc. Recent Developments/Updates
Table 30. Bio-Techne Corporation Basic Information, Manufacturing Base and Competitors
Table 31. Bio-Techne Corporation Major Business
Table 32. Bio-Techne Corporation CD34+ Cell Selection Equipment Product and Services
Table 33. Bio-Techne Corporation CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Bio-Techne Corporation Recent Developments/Updates
Table 35. Revvity, Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Revvity, Inc. Major Business
Table 37. Revvity, Inc. CD34+ Cell Selection Equipment Product and Services
Table 38. Revvity, Inc. CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Revvity, Inc. Recent Developments/Updates
Table 40. GenScript Biotech Corporation Basic Information, Manufacturing Base and Competitors
Table 41. GenScript Biotech Corporation Major Business
Table 42. GenScript Biotech Corporation CD34+ Cell Selection Equipment Product and Services
Table 43. GenScript Biotech Corporation CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. GenScript Biotech Corporation Recent Developments/Updates
Table 45. Beaver Biomedical Engineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 46. Beaver Biomedical Engineering Co., Ltd. Major Business
Table 47. Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Product and Services
Table 48. Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Beaver Biomedical Engineering Co., Ltd. Recent Developments/Updates
Table 50. Suzhou Xinxie Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 51. Suzhou Xinxie Biotechnology Co., Ltd. Major Business
Table 52. Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Product and Services
Table 53. Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Suzhou Xinxie Biotechnology Co., Ltd. Recent Developments/Updates
Table 55. APExBIO Technology LLC Basic Information, Manufacturing Base and Competitors
Table 56. APExBIO Technology LLC Major Business
Table 57. APExBIO Technology LLC CD34+ Cell Selection Equipment Product and Services
Table 58. APExBIO Technology LLC CD34+ Cell Selection Equipment Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. APExBIO Technology LLC Recent Developments/Updates
Table 60. Global CD34+ Cell Selection Equipment Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 61. Global CD34+ Cell Selection Equipment Revenue by Manufacturer (2021-2026) & (USD Million)
Table 62. Global CD34+ Cell Selection Equipment Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 63. Market Position of Manufacturers in CD34+ Cell Selection Equipment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 64. Head Office and CD34+ Cell Selection Equipment Production Site of Key Manufacturer
Table 65. CD34+ Cell Selection Equipment Market: Company Product Type Footprint
Table 66. CD34+ Cell Selection Equipment Market: Company Product Application Footprint
Table 67. CD34+ Cell Selection Equipment New Market Entrants and Barriers to Market Entry
Table 68. CD34+ Cell Selection Equipment Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global CD34+ Cell Selection Equipment Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 70. Global CD34+ Cell Selection Equipment Sales Quantity by Region (2021-2026) & (Units)
Table 71. Global CD34+ Cell Selection Equipment Sales Quantity by Region (2027-2032) & (Units)
Table 72. Global CD34+ Cell Selection Equipment Consumption Value by Region (2021-2026) & (USD Million)
Table 73. Global CD34+ Cell Selection Equipment Consumption Value by Region (2027-2032) & (USD Million)
Table 74. Global CD34+ Cell Selection Equipment Average Price by Region (2021-2026) & (US$/Unit)
Table 75. Global CD34+ Cell Selection Equipment Average Price by Region (2027-2032) & (US$/Unit)
Table 76. Global CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2026) & (Units)
Table 77. Global CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2027-2032) & (Units)
Table 78. Global CD34+ Cell Selection Equipment Consumption Value by Technology Route (2021-2026) & (USD Million)
Table 79. Global CD34+ Cell Selection Equipment Consumption Value by Technology Route (2027-2032) & (USD Million)
Table 80. Global CD34+ Cell Selection Equipment Average Price by Technology Route (2021-2026) & (US$/Unit)
Table 81. Global CD34+ Cell Selection Equipment Average Price by Technology Route (2027-2032) & (US$/Unit)
Table 82. Global CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2026) & (Units)
Table 83. Global CD34+ Cell Selection Equipment Sales Quantity by Application (2027-2032) & (Units)
Table 84. Global CD34+ Cell Selection Equipment Consumption Value by Application (2021-2026) & (USD Million)
Table 85. Global CD34+ Cell Selection Equipment Consumption Value by Application (2027-2032) & (USD Million)
Table 86. Global CD34+ Cell Selection Equipment Average Price by Application (2021-2026) & (US$/Unit)
Table 87. Global CD34+ Cell Selection Equipment Average Price by Application (2027-2032) & (US$/Unit)
Table 88. North America CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2026) & (Units)
Table 89. North America CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2027-2032) & (Units)
Table 90. North America CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2026) & (Units)
Table 91. North America CD34+ Cell Selection Equipment Sales Quantity by Application (2027-2032) & (Units)
Table 92. North America CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2026) & (Units)
Table 93. North America CD34+ Cell Selection Equipment Sales Quantity by Country (2027-2032) & (Units)
Table 94. North America CD34+ Cell Selection Equipment Consumption Value by Country (2021-2026) & (USD Million)
Table 95. North America CD34+ Cell Selection Equipment Consumption Value by Country (2027-2032) & (USD Million)
Table 96. Europe CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2026) & (Units)
Table 97. Europe CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2027-2032) & (Units)
Table 98. Europe CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2026) & (Units)
Table 99. Europe CD34+ Cell Selection Equipment Sales Quantity by Application (2027-2032) & (Units)
Table 100. Europe CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2026) & (Units)
Table 101. Europe CD34+ Cell Selection Equipment Sales Quantity by Country (2027-2032) & (Units)
Table 102. Europe CD34+ Cell Selection Equipment Consumption Value by Country (2021-2026) & (USD Million)
Table 103. Europe CD34+ Cell Selection Equipment Consumption Value by Country (2027-2032) & (USD Million)
Table 104. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2026) & (Units)
Table 105. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2027-2032) & (Units)
Table 106. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2026) & (Units)
Table 107. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Application (2027-2032) & (Units)
Table 108. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Region (2021-2026) & (Units)
Table 109. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity by Region (2027-2032) & (Units)
Table 110. Asia-Pacific CD34+ Cell Selection Equipment Consumption Value by Region (2021-2026) & (USD Million)
Table 111. Asia-Pacific CD34+ Cell Selection Equipment Consumption Value by Region (2027-2032) & (USD Million)
Table 112. South America CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2026) & (Units)
Table 113. South America CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2027-2032) & (Units)
Table 114. South America CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2026) & (Units)
Table 115. South America CD34+ Cell Selection Equipment Sales Quantity by Application (2027-2032) & (Units)
Table 116. South America CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2026) & (Units)
Table 117. South America CD34+ Cell Selection Equipment Sales Quantity by Country (2027-2032) & (Units)
Table 118. South America CD34+ Cell Selection Equipment Consumption Value by Country (2021-2026) & (USD Million)
Table 119. South America CD34+ Cell Selection Equipment Consumption Value by Country (2027-2032) & (USD Million)
Table 120. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2021-2026) & (Units)
Table 121. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Technology Route (2027-2032) & (Units)
Table 122. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Application (2021-2026) & (Units)
Table 123. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Application (2027-2032) & (Units)
Table 124. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Country (2021-2026) & (Units)
Table 125. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity by Country (2027-2032) & (Units)
Table 126. Middle East & Africa CD34+ Cell Selection Equipment Consumption Value by Country (2021-2026) & (USD Million)
Table 127. Middle East & Africa CD34+ Cell Selection Equipment Consumption Value by Country (2027-2032) & (USD Million)
Table 128. CD34+ Cell Selection Equipment Raw Material
Table 129. Key Manufacturers of CD34+ Cell Selection Equipment Raw Materials
Table 130. CD34+ Cell Selection Equipment Typical Distributors
Table 131. CD34+ Cell Selection Equipment Typical Customers
LIST OF FIGURES
Figure 1. CD34+ Cell Selection Equipment Picture
Figure 2. Global CD34+ Cell Selection Equipment Revenue by Technology Route, (USD Million), 2021 & 2025 & 2032
Figure 3. Global CD34+ Cell Selection Equipment Revenue Market Share by Technology Route in 2025
Figure 4. Column-Based Immunomagnetic Selection Examples
Figure 5. Column-Free Immunomagnetic Selection Examples
Figure 6. Buoyancy-Activated Microbubble Sorting Examples
Figure 7. Global CD34+ Cell Selection Equipment Revenue by Product Delivery Form, (USD Million), 2021 & 2025 & 2032
Figure 8. Global CD34+ Cell Selection Equipment Revenue Market Share by Product Delivery Form in 2025
Figure 9. Closed Clinical System Examples
Figure 10. Laboratory Selection Kit Examples
Figure 11. Platform-Based Selection Instrument Examples
Figure 12. Global CD34+ Cell Selection Equipment Revenue by CD34+ Cell Acquisition Workflow, (USD Million), 2021 & 2025 & 2032
Figure 13. Global CD34+ Cell Selection Equipment Revenue Market Share by CD34+ Cell Acquisition Workflow in 2025
Figure 14. Direct Positive Selection Examples
Figure 15. Direct Negative Enrichment Examples
Figure 16. Pre-Enrichment Followed By Positive Selection Examples
Figure 17. Global CD34+ Cell Selection Equipment Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Global CD34+ Cell Selection Equipment Revenue Market Share by Application in 2025
Figure 19. Clinical Transplant Cell Preparation Examples
Figure 20. Research-Use Cell Isolation Examples
Figure 21. Process Development And Translational Research Examples
Figure 22. Global CD34+ Cell Selection Equipment Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global CD34+ Cell Selection Equipment Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global CD34+ Cell Selection Equipment Sales Quantity (2021-2032) & (Units)
Figure 25. Global CD34+ Cell Selection Equipment Price (2021-2032) & (US$/Unit)
Figure 26. Global CD34+ Cell Selection Equipment Sales Quantity Market Share by Manufacturer in 2025
Figure 27. Global CD34+ Cell Selection Equipment Revenue Market Share by Manufacturer in 2025
Figure 28. Producer Shipments of CD34+ Cell Selection Equipment by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 29. Top 3 CD34+ Cell Selection Equipment Manufacturer (Revenue) Market Share in 2025
Figure 30. Top 6 CD34+ Cell Selection Equipment Manufacturer (Revenue) Market Share in 2025
Figure 31. Global CD34+ Cell Selection Equipment Sales Quantity Market Share by Region (2021-2032)
Figure 32. Global CD34+ Cell Selection Equipment Consumption Value Market Share by Region (2021-2032)
Figure 33. North America CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 34. Europe CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 35. Asia-Pacific CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 36. South America CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 37. Middle East & Africa CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 38. Global CD34+ Cell Selection Equipment Sales Quantity Market Share by Technology Route (2021-2032)
Figure 39. Global CD34+ Cell Selection Equipment Consumption Value Market Share by Technology Route (2021-2032)
Figure 40. Global CD34+ Cell Selection Equipment Average Price by Technology Route (2021-2032) & (US$/Unit)
Figure 41. Global CD34+ Cell Selection Equipment Sales Quantity Market Share by Application (2021-2032)
Figure 42. Global CD34+ Cell Selection Equipment Revenue Market Share by Application (2021-2032)
Figure 43. Global CD34+ Cell Selection Equipment Average Price by Application (2021-2032) & (US$/Unit)
Figure 44. North America CD34+ Cell Selection Equipment Sales Quantity Market Share by Technology Route (2021-2032)
Figure 45. North America CD34+ Cell Selection Equipment Sales Quantity Market Share by Application (2021-2032)
Figure 46. North America CD34+ Cell Selection Equipment Sales Quantity Market Share by Country (2021-2032)
Figure 47. North America CD34+ Cell Selection Equipment Consumption Value Market Share by Country (2021-2032)
Figure 48. United States CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe CD34+ Cell Selection Equipment Sales Quantity Market Share by Technology Route (2021-2032)
Figure 52. Europe CD34+ Cell Selection Equipment Sales Quantity Market Share by Application (2021-2032)
Figure 53. Europe CD34+ Cell Selection Equipment Sales Quantity Market Share by Country (2021-2032)
Figure 54. Europe CD34+ Cell Selection Equipment Consumption Value Market Share by Country (2021-2032)
Figure 55. Germany CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 56. France CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 57. United Kingdom CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 58. Russia CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 59. Italy CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 60. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity Market Share by Technology Route (2021-2032)
Figure 61. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity Market Share by Application (2021-2032)
Figure 62. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity Market Share by Region (2021-2032)
Figure 63. Asia-Pacific CD34+ Cell Selection Equipment Consumption Value Market Share by Region (2021-2032)
Figure 64. China CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 65. Japan CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 66. South Korea CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 67. India CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 68. Southeast Asia CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 69. Australia CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 70. South America CD34+ Cell Selection Equipment Sales Quantity Market Share by Technology Route (2021-2032)
Figure 71. South America CD34+ Cell Selection Equipment Sales Quantity Market Share by Application (2021-2032)
Figure 72. South America CD34+ Cell Selection Equipment Sales Quantity Market Share by Country (2021-2032)
Figure 73. South America CD34+ Cell Selection Equipment Consumption Value Market Share by Country (2021-2032)
Figure 74. Brazil CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 75. Argentina CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 76. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity Market Share by Technology Route (2021-2032)
Figure 77. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity Market Share by Application (2021-2032)
Figure 78. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity Market Share by Country (2021-2032)
Figure 79. Middle East & Africa CD34+ Cell Selection Equipment Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 81. Egypt CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 82. Saudi Arabia CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 83. South Africa CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 84. CD34+ Cell Selection Equipment Market Drivers
Figure 85. CD34+ Cell Selection Equipment Market Restraints
Figure 86. CD34+ Cell Selection Equipment Market Trends
Figure 87. Porters Five Forces Analysis
Figure 88. Manufacturing Cost Structure Analysis of CD34+ Cell Selection Equipment in 2025
Figure 89. Manufacturing Process Analysis of CD34+ Cell Selection Equipment
Figure 90. CD34+ Cell Selection Equipment Industrial Chain
Figure 91. Sales Channel: Direct to End-User vs Distributors
Figure 92. Direct Channel Pros & Cons
Figure 93. Indirect Channel Pros & Cons
Figure 94. Methodology
Figure 95. Research Process and Data Source
Figure 1. CD34+ Cell Selection Equipment Picture
Figure 2. Global CD34+ Cell Selection Equipment Revenue by Technology Route, (USD Million), 2021 & 2025 & 2032
Figure 3. Global CD34+ Cell Selection Equipment Revenue Market Share by Technology Route in 2025
Figure 4. Column-Based Immunomagnetic Selection Examples
Figure 5. Column-Free Immunomagnetic Selection Examples
Figure 6. Buoyancy-Activated Microbubble Sorting Examples
Figure 7. Global CD34+ Cell Selection Equipment Revenue by Product Delivery Form, (USD Million), 2021 & 2025 & 2032
Figure 8. Global CD34+ Cell Selection Equipment Revenue Market Share by Product Delivery Form in 2025
Figure 9. Closed Clinical System Examples
Figure 10. Laboratory Selection Kit Examples
Figure 11. Platform-Based Selection Instrument Examples
Figure 12. Global CD34+ Cell Selection Equipment Revenue by CD34+ Cell Acquisition Workflow, (USD Million), 2021 & 2025 & 2032
Figure 13. Global CD34+ Cell Selection Equipment Revenue Market Share by CD34+ Cell Acquisition Workflow in 2025
Figure 14. Direct Positive Selection Examples
Figure 15. Direct Negative Enrichment Examples
Figure 16. Pre-Enrichment Followed By Positive Selection Examples
Figure 17. Global CD34+ Cell Selection Equipment Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Global CD34+ Cell Selection Equipment Revenue Market Share by Application in 2025
Figure 19. Clinical Transplant Cell Preparation Examples
Figure 20. Research-Use Cell Isolation Examples
Figure 21. Process Development And Translational Research Examples
Figure 22. Global CD34+ Cell Selection Equipment Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global CD34+ Cell Selection Equipment Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global CD34+ Cell Selection Equipment Sales Quantity (2021-2032) & (Units)
Figure 25. Global CD34+ Cell Selection Equipment Price (2021-2032) & (US$/Unit)
Figure 26. Global CD34+ Cell Selection Equipment Sales Quantity Market Share by Manufacturer in 2025
Figure 27. Global CD34+ Cell Selection Equipment Revenue Market Share by Manufacturer in 2025
Figure 28. Producer Shipments of CD34+ Cell Selection Equipment by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 29. Top 3 CD34+ Cell Selection Equipment Manufacturer (Revenue) Market Share in 2025
Figure 30. Top 6 CD34+ Cell Selection Equipment Manufacturer (Revenue) Market Share in 2025
Figure 31. Global CD34+ Cell Selection Equipment Sales Quantity Market Share by Region (2021-2032)
Figure 32. Global CD34+ Cell Selection Equipment Consumption Value Market Share by Region (2021-2032)
Figure 33. North America CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 34. Europe CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 35. Asia-Pacific CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 36. South America CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 37. Middle East & Africa CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 38. Global CD34+ Cell Selection Equipment Sales Quantity Market Share by Technology Route (2021-2032)
Figure 39. Global CD34+ Cell Selection Equipment Consumption Value Market Share by Technology Route (2021-2032)
Figure 40. Global CD34+ Cell Selection Equipment Average Price by Technology Route (2021-2032) & (US$/Unit)
Figure 41. Global CD34+ Cell Selection Equipment Sales Quantity Market Share by Application (2021-2032)
Figure 42. Global CD34+ Cell Selection Equipment Revenue Market Share by Application (2021-2032)
Figure 43. Global CD34+ Cell Selection Equipment Average Price by Application (2021-2032) & (US$/Unit)
Figure 44. North America CD34+ Cell Selection Equipment Sales Quantity Market Share by Technology Route (2021-2032)
Figure 45. North America CD34+ Cell Selection Equipment Sales Quantity Market Share by Application (2021-2032)
Figure 46. North America CD34+ Cell Selection Equipment Sales Quantity Market Share by Country (2021-2032)
Figure 47. North America CD34+ Cell Selection Equipment Consumption Value Market Share by Country (2021-2032)
Figure 48. United States CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe CD34+ Cell Selection Equipment Sales Quantity Market Share by Technology Route (2021-2032)
Figure 52. Europe CD34+ Cell Selection Equipment Sales Quantity Market Share by Application (2021-2032)
Figure 53. Europe CD34+ Cell Selection Equipment Sales Quantity Market Share by Country (2021-2032)
Figure 54. Europe CD34+ Cell Selection Equipment Consumption Value Market Share by Country (2021-2032)
Figure 55. Germany CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 56. France CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 57. United Kingdom CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 58. Russia CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 59. Italy CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 60. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity Market Share by Technology Route (2021-2032)
Figure 61. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity Market Share by Application (2021-2032)
Figure 62. Asia-Pacific CD34+ Cell Selection Equipment Sales Quantity Market Share by Region (2021-2032)
Figure 63. Asia-Pacific CD34+ Cell Selection Equipment Consumption Value Market Share by Region (2021-2032)
Figure 64. China CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 65. Japan CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 66. South Korea CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 67. India CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 68. Southeast Asia CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 69. Australia CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 70. South America CD34+ Cell Selection Equipment Sales Quantity Market Share by Technology Route (2021-2032)
Figure 71. South America CD34+ Cell Selection Equipment Sales Quantity Market Share by Application (2021-2032)
Figure 72. South America CD34+ Cell Selection Equipment Sales Quantity Market Share by Country (2021-2032)
Figure 73. South America CD34+ Cell Selection Equipment Consumption Value Market Share by Country (2021-2032)
Figure 74. Brazil CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 75. Argentina CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 76. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity Market Share by Technology Route (2021-2032)
Figure 77. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity Market Share by Application (2021-2032)
Figure 78. Middle East & Africa CD34+ Cell Selection Equipment Sales Quantity Market Share by Country (2021-2032)
Figure 79. Middle East & Africa CD34+ Cell Selection Equipment Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 81. Egypt CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 82. Saudi Arabia CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 83. South Africa CD34+ Cell Selection Equipment Consumption Value (2021-2032) & (USD Million)
Figure 84. CD34+ Cell Selection Equipment Market Drivers
Figure 85. CD34+ Cell Selection Equipment Market Restraints
Figure 86. CD34+ Cell Selection Equipment Market Trends
Figure 87. Porters Five Forces Analysis
Figure 88. Manufacturing Cost Structure Analysis of CD34+ Cell Selection Equipment in 2025
Figure 89. Manufacturing Process Analysis of CD34+ Cell Selection Equipment
Figure 90. CD34+ Cell Selection Equipment Industrial Chain
Figure 91. Sales Channel: Direct to End-User vs Distributors
Figure 92. Direct Channel Pros & Cons
Figure 93. Indirect Channel Pros & Cons
Figure 94. Methodology
Figure 95. Research Process and Data Source
